Denosumab (Prolia) for the treatment of osteoporosis

Moshi M, Nicolopoulos K, Gaget V, Ampofo A, Ma N, Vreugdenburg T
Record ID 32018004605
English
Details
Project Status: Completed
Year Published: 2022
Requestor: Federal Office of Public Health.
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Australia
MeSH Terms
  • Bone Density
  • Bone Density Conservation Agents
  • Osteoporosis
  • Denosumab
  • Diphosphonates
  • Selective Estrogen Receptor Modulators
  • Neoplasms
  • Ibandronic Acid
  • Hormones
  • Risedronic Acid
  • Zoledronic Acid
Contact
Organisation Name: Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
Contact Address: ASERNIP-S 24 King William Street, Kent Town SA 5067 Australia Tel: +61 8 8219 0900
Contact Name: racs.asernip@surgeons.org
Contact Email: racs.asernip@surgeons.org
Copyright: Australian Safety and Efficacy Register of New Interventional Procedures - Surgical
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.